Many tumor cells over-express a ligand, the programmed death-ligand 1 (PD-L1), which binds inhibitory receptors expressed on T lymphocytes, such as cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and programmed death protein-1 (PD-1). This evidence concerns the gene CTLA4 and neoplasm.